Position in EXEL
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$9,594,604
+$3,729,526 QoQ
Shares Held
176,339
+29.0% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#131
of 751 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $302,411,362 across 140 Biotechnology names. EXEL ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
941,283 | $124,936,492 | |
| 2 | CAPR |
Capricor Therapeutics, Inc.
|
802,732 | $19,329,786 | |
| 3 | ORMP |
Oramed Pharmaceuticals Inc.
|
3,810,540 | $18,328,697 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,705 | $15,252,094 | |
| 5 | INCY |
Incyte Corp
|
116,207 | $13,173,225 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,126 | $12,549,366 | |
| 7 | EXEL |
Exelixis, Inc.
This page
|
176,339 | $9,594,604 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
102,823 | $8,940,459 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,594,604 | 176,339 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $5,865,078 | 136,747 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,301,877 | 143,780 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,867,046 | 69,420 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,833,506 | 64,281 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,665,439 | 72,195 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,539,159 | 46,221 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,256,031 | 48,402 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,048,000 | 46,640 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,115,191 | 46,995 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,046,923 | 43,640 | Shares | Sole | 2024-02-15 | |
| 2023-06-30 | $711,656 | 37,240 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $631,465 | 32,533 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $458,150 | 28,563 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $570,328 | 36,373 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $801,465 | 38,495 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $710,273 | 31,331 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $411,373 | 22,504 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $561,436 | 26,558 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $604,302 | 33,167 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $1,147,261 | 57,163 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,563,015 | 63,927 | Shares | Sole | 2020-12-10 | |
| 2020-06-30 | $1,524,369 | 64,211 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,358,571 | 78,895 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||